AL-1095
Clinical data | |
---|---|
ATC code | none |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | 54549-19-8 |
PubChem (CID) | 3041659 |
ChemSpider | 2304906 |
Chemical and physical data | |
Formula | C20H22ClNO |
Molar mass | 327.139 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
AL-1095,[1] developed by Aldrich, is a centrally acting stimulant drug with comparable effects to amphetamine,[2] developed by Bristol in the 1970s.[3]
See also
References
- ↑ US Patent 3506673 -2-(4'HALO)-BENZHYDRYL-3-QUINUCLIDINOLS
- ↑ Hedblom, P.; Grinspoon, L. (1975). The Speed Culture: Amphetamine Use and Abuse in America. Cambridge: Harvard University Press. p. 50. ISBN 0-674-83192-6.
- ↑ Warawa, E. J.; Mueller, N. J.; Gylys, J. A. (1975). "Quinuclidine Chemistry. 3. β-cis-2-(4'-Chlorobenzhydryl)-3-quinuclidinol, a New Central Nervous System Stimulant. Importance of the Benzhydryl Configuration". Journal of Medicinal Chemistry. 18 (1): 71–74. doi:10.1021/jm00235a016. PMID 803245.
This article is issued from Wikipedia - version of the 10/21/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.